Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers

被引:31
作者
Perkins, Rebecca B. [1 ]
Chigurupati, Nagasudha L. [1 ]
Apte, Gauri [1 ]
Vercruysse, Jessica [1 ]
Wall-Haas, Constance [2 ]
Rosenquist, Anna [3 ]
Lee, Laura [2 ]
Clark, Jack A. [4 ]
Pierre-Joseph, Natalie [1 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Harvard Vanguard Med Associates, Chelmsford, MA USA
[3] Harvard Vanguard Med Associates, Burlington, MA USA
[4] Boston Univ, Sch Publ Hlth, Edith Nourse Rogers Mem Vet Hosp Bedford, Boston, MA USA
关键词
HPV vaccination; vaccine series completion; qualitative research; parents' attitudes; physician attitudes; HUMAN-PAPILLOMAVIRUS VACCINATION; YOUNG-WOMEN; DECISION-MAKING; NATIONAL-HEALTH; RATES; COMPLETION; SAFETY; FACILITATORS; ASSOCIATION; BARRIERS;
D O I
10.1080/21645515.2015.1118594
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: To describe why adolescent females who initiated HPV vaccination completed or did not complete the series.Methods: Semi-structured interviews were conducted with parents/guardians of 11-17year old female adolescents and their pediatric primary care providers in one inner-city public clinic and three private practices to ascertain why girls who initiated HPV vaccination did or did not complete the series. Qualitative analysis was used to identify perceived barriers and facilitators of completion.Results: 65 parents/guardians participated: 37 whose daughters received 1 or 2 HPV vaccine doses and 28 whose daughters completed the series. 89% (n = 33) of parents who did not complete the series intended to do so, but were not reminded by the clinic or encountered logistical barriers. Four (11%) decided to stop the vaccine series. 33 providers participated: 24 physicians, 3 nurse practitioners, and 6 registered nurses. Half (n = 14, 52%) of the providers said they told parents when the next doses were due but relied on parents to schedule appointments, 11 (41%) scheduled the second dose when the first dose was given, and 2 (7%) tried to immunize patients when they returned for other appointments. None of the four practices had a reminder/recall system in place to ensure series completion. Of note, neither parents nor providers stated that the need for three doses was a barrier to series completion.Conclusions: Most failure to complete the HPV vaccine series occurred because providers expected parents to make appointments while parents expected to be reminded. Increased use of reminder/recall systems and team-based care with clear communication of expectations regarding appointment scheduling could increase completion rates.
引用
收藏
页码:1528 / 1535
页数:8
相关论文
共 36 条
  • [21] COMPLETION OF THE HUMAN PAPILLOMAVIRUS VACCINE SERIES IN FEMALES ATTENDING AN URBAN IMMUNIZATION CLINIC
    Kouyoumdjian, Fiona G.
    Bailowitz, Anne
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (08) : 718 - 719
  • [22] Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Markowitz, Lauri E.
    Hariri, Susan
    Lin, Carol
    Dunne, Eileen F.
    Steinau, Martin
    McQuillan, Geraldine
    Unger, Elizabeth R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (03) : 385 - 393
  • [23] Increasing HPV Vaccination Series Completion Rates via Text Message Reminders
    Matheson, Elaine C.
    Derouin, Anne
    Gagliano, Martha
    Thompson, Julie A.
    Blood-Siegfried, Jane
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2014, 28 (04) : E35 - E39
  • [24] Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008-2011
    Niccolai, Linda M.
    Julian, Pamela J.
    Meek, James I.
    McBride, Vanessa
    Hadler, James L.
    Sosa, Lynn E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (08) : 1446 - 1450
  • [25] The Architecture of Provider-Parent Vaccine Discussions at Health Supervision Visits
    Opel, Douglas J.
    Heritage, John
    Taylor, James A.
    Mangione-Smith, Rita
    Salas, Halle Showalter
    DeVere, Victoria
    Zhou, Chuan
    Robinson, Jeffrey D.
    [J]. PEDIATRICS, 2013, 132 (06) : 1037 - 1046
  • [26] Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
    Paovonen, J.
    Naud, P.
    Salmeron, J.
    Wheeler, C. M.
    Chow, S-N
    Apter, D.
    Kitchener, H.
    Castellsague, X.
    Teixeira, J. C.
    Skinner, S. R.
    Hedrick, J.
    Jaisamrarn, U.
    Limson, G.
    Garland, S.
    Szarewski, A.
    Romanowski, B.
    Aoki, F. Y.
    Schwarz, T. F.
    Poppe, W. A. J.
    Bosch, F. X.
    Jenkins, D.
    Hardt, K.
    Zahaf, T.
    Descamps, D.
    Struyf, F.
    Lehtinen, M.
    Dubin, G.
    [J]. LANCET, 2009, 374 (9686) : 301 - 314
  • [27] Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study
    Perkins, Rebecca B.
    Clark, Jack A.
    Apte, Gauri
    Vercruysse, Jessica L.
    Sumner, Justen J.
    Wall-Haas, Constance L.
    Rosenquist, Anna W.
    Pierre-Joseph, Natalie
    [J]. PEDIATRICS, 2014, 134 (03) : E666 - E674
  • [28] Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
    Pomfret, T. C.
    Gagnon, J. M., Jr.
    Gilchrist, A. T.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (01) : 1 - 9
  • [29] Pourat N, 2012, AM J MANAG CARE, V18, P320
  • [30] Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review
    Rambout, Lisa
    Tashkandi, Mariam
    Hopkins, Laura
    Tricco, Andrea C.
    [J]. PREVENTIVE MEDICINE, 2014, 58 : 22 - 32